Congenital lung malformations, primary and secondary, contribute to an impo
rtant portion of pediatric thoracic surgery. One purpose of this report is
to outline the close relation in terms of embryology and clinical presentat
ion of congenital parenchymatous pulmonary malformations. In a retrospectiv
e study we also aim to evaluate our experience with the diagnosis and surgi
cal management of congenital parenchymatous bronchopulmonary malformations
and to compare our data with the literature. From January 1979 to December
1996 a series of 48 patients, 30 males (62.5%) and 18 females (37.5%), were
operated on for congenital bronchopulmonary malformations. Pulmonary seque
stration, bronchogenic cysts, congenital lobar emphysema, and congenital cy
stic adenomatoid malformation were seen in 16, 13, 5, and 14 patients, resp
ectively. The first clinical symptoms occurred at a mean age of 8.8 years (
1 day to 62 years), and the mean age at the time of surgical intervention w
as 9.3 years (1 day to 62 years). The maximum time between first symptoms a
nd surgical treatment was 27 years. A lobectomy was performed in 22 cases;
in the other patients more lung-preserving surgery such as enucleation or s
equestrectomy was performed. Only one postoperative death occurred followin
g lobectomy for pulmonary sequestration, and it was due to pulmonary hypopl
asia and pulmonary hypertension. Eleven other patients presented with posts
urgical complications: pneumothorax (n = 5), pleural effusion (n = 3), prol
onged air leak (n = 2), portal vein thrombosis (n = 1), and hemorrhage requ
iring reintervention (n = 1). We conclude that any thoracic cystic lesion e
xpanding on chest radiography should be an indication for surgical resectio
n, even if asymptomatic, because of the risk of pulmonary compression, infe
ction, or malignant degeneration. In the few cases of a fetal intrathoracic
mass, prenatal diagnosis and intrauterine intervention may be indicated, a
nd these indications are also discussed.